bioRxivBiochemistry
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug Carmofur
Z. Jin, Y. Zhao, Y. Sun, B. Zhang, H. Wang, Y. Wu, Y. Zhu, C. Zhu, T. Hu, X. Du, Y. Duan, J. Yu, X. Yang, X. Yang, K. Yang, X. Liu, L. W. Guddat, G. Xiao, L. Zhang, H. Yang, Z. Rao
Abstract
The antineoplastic drug Carmofur was shown to inhibit SARS-CoV-2 main protease (Mpro). Here the X-ray crystal structure of Mpro in complex with Carmofur reveals that the carbonyl reactive group of Carmofur is covalently bound to catalytic Cys145, whereas its fatty acid tail occupies the hydrophobic S2 subsite. Carmofur inhibits viral replication in cells (EC50 = 24.30 M) and it is a promising lead compound to develop new antiviral treatment for COVID-19.
- assay: structural biology
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synthesis and Evaluation of Carmofur Analogs as Antiproliferative Agents, Inhibitors to the Main Protease (Mpro) of SARS-CoV-2, and Membrane Rupture-Inducing Agents
Tiffany Gu, Amber Lu, … Edward Njoo·Discover Chemistry.Peer-reviewed·Apr 7, 2025
- Structural basis for the inhibition of coronaviral main proteases by PF-00835231
Xuelan Zhou, Xiaolu Lu, … Jian Li·Acta Biochimica et Biophysica SinicaPeer-reviewed·Jul 29, 2024
- The N-Terminal Carbamate is Key to High Cellular and Antiviral Potency for Boceprevir-Based SARS-CoV-2 Main Protease Inhibitors
Y. R. Alugubelli, Z. Z. Geng, … W. R. Liu·bioRxiv·Dec 18, 2021
- Structure-based identification of naphthoquinones and derivatives as novel inhibitors of main protease Mpro and papain-like protease PLpro of SARS-CoV-2
L. H. Santos, T. Kronenberger, … R. Ferreira·bioRxiv·Jan 5, 2022
- Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors
- Novel inhibitors against COVID-19 main protease suppressed viral infection
V. Ramachandran, Y. Liu, … R. Chang·bioRxiv·Nov 5, 2022